Gentherm lifts 2026 guidance as buyback and Modine deal advance
Jul 23, 2026, 6:03 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Guidance raise, sizable buyback, and progress on a meaningful M&A transaction (Modine) are classic earnings/capital-allocation catalysts that can support multiple expansion and upside in THRM’s multiple, especially with improved liquidity and deleveraging potential.
AI summary
What happened, with direct paths to the underlying reporting
Gentherm posted Q2 revenue of $416.2M, up 11% YoY with ex-FX growth of 9.5% and Automotive up 9.8%. The company raised its 2026 guidance and authorized a $400M stock buyback. The Modine Performance Technologies merger remains on track for a late-2026 close, while the Innovative Medical Equipment ThermaZone acquisition broadens healthcare channel access.
Gentherm Q2 revenue $416.2M, up 11% YoY; ex-FX growth 9.5%.
Automotive Climate and Comfort revenue +14.1% YoY; outpaced regional vehicle output by 14pp.
Board authorized new stock repurchase up to $400M; replaces prior program.
M&A updates: Modine Performance Technologies deal on track to close by early Q4 2026; Innovative Medical Equipment expands ThermaZone offering.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event